LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 14 of 497
Next
>>
>
326 to 350 of 12420 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Relative Growth Rate After Treatment
BT-20	Withaferin A	0.04	uM	LJP6	2	G18	72	hr	1657	5616	5505	1.0200	1.0287
BT-20	Withaferin A	0.04	uM	LJP6	3	G18	72	hr	1657	5672	5505	1.0302	1.0432
BT-20	WYE-125132	0.04	uM	LJP6	1	L12	72	hr	1657	3230	5505	0.5867	0.4086
BT-20	WYE-125132	0.04	uM	LJP6	2	L12	72	hr	1657	3083	5505	0.5600	0.3704
BT-20	WYE-125132	0.04	uM	LJP6	3	L12	72	hr	1657	2989	5505	0.5429	0.3460
BT-20	WZ3105	0.04	uM	LJP5	1	D24	72	hr	1657	2607	5505	0.4735	0.2467
BT-20	WZ3105	0.04	uM	LJP5	2	D24	72	hr	1657	2411	5505	0.4379	0.1958
BT-20	WZ3105	0.04	uM	LJP5	3	D24	72	hr	1657	2687	5505	0.4880	0.2675
BT-20	XMD11-50	0.04	uM	LJP6	1	P12	72	hr	1657	5053	5505	0.9178	0.8824
BT-20	XMD11-50	0.04	uM	LJP6	2	P12	72	hr	1657	4709	5505	0.8553	0.7930
BT-20	XMD11-50	0.04	uM	LJP6	3	P12	72	hr	1657	4872	5505	0.8849	0.8353
BT-20	Y39983	0.04	uM	LJP6	1	P06	72	hr	1657	5460	5505	0.9917	0.9881
BT-20	Y39983	0.04	uM	LJP6	2	P06	72	hr	1657	5313	5505	0.9650	0.9499
BT-20	Y39983	0.04	uM	LJP6	3	P06	72	hr	1657	5482	5505	0.9957	0.9939
BT-20	YM 201636	0.04	uM	LJP5	1	N12	72	hr	1657	6080	5505	1.1043	1.1493
BT-20	YM 201636	0.04	uM	LJP5	2	N12	72	hr	1657	5860	5505	1.0644	1.0921
BT-20	YM 201636	0.04	uM	LJP5	3	N12	72	hr	1657	5587	5505	1.0148	1.0211
BT-20	ZSTK474	0.04	uM	LJP6	1	M18	72	hr	1657	5385	5505	0.9781	0.9686
BT-20	ZSTK474	0.04	uM	LJP6	2	M18	72	hr	1657	5497	5505	0.9984	0.9978
BT-20	ZSTK474	0.04	uM	LJP6	3	M18	72	hr	1657	5251	5505	0.9537	0.9338
BT-20	Afatinib	0.12	uM	LJP6	1	G23	72	hr	1657	4431	5505	0.8048	0.7207
BT-20	Afatinib	0.12	uM	LJP6	2	G23	72	hr	1657	4543	5505	0.8252	0.7498
BT-20	Afatinib	0.12	uM	LJP6	3	G23	72	hr	1657	4569	5505	0.8299	0.7566
BT-20	Sigma A6730	0.12	uM	LJP5	1	B23	72	hr	1657	4971	5505	0.9029	0.8611
BT-20	Sigma A6730	0.12	uM	LJP5	2	B23	72	hr	1657	4759	5505	0.8644	0.8060

|<
<<
Previous
Page 14 of 497
Next
>>
>
326 to 350 of 12420 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)